These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9174917)

  • 1. Affinity of human anti-factor VIII antibodies for functional polystyrene supports.
    Dahri L; Stoltz JF; Boisson-Vidal C; Muller D; Jozefonvicz J
    J Mol Recognit; 1996; 9(5-6):401-6. PubMed ID: 9174917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosyl sulfamide derivatives as ligands for affinity adsorption of anti FVIII antibodies.
    Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J
    J Biomater Sci Polym Ed; 1994; 6(8):695-705. PubMed ID: 7703186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic sorbents for removal of factor VIII inhibitors from haemophilic A plasma.
    Dahri L; Boisson-Vidal C; Regnault V; Muller D; Sultan Y; Stolz JF
    J Chromatogr B Biomed Appl; 1995 Feb; 664(1):47-54. PubMed ID: 7757240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins.
    Huguet HC; Lasne D; Rothschild C; Siali R; Jozefonvicz J
    Thromb Haemost; 2004 Feb; 91(2):259-66. PubMed ID: 14961152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adsorption of immunoglobulin G and anti-factor VIII inhibitory antibody from haemophiliac plasma to derivatized polystyrenes.
    Cornelius RM; Dahri L; Boisson-Vidal C; Muller D; Jozefonvicz J; Brash JL
    Biomaterials; 1997 Mar; 18(5):429-36. PubMed ID: 9061184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polystyrene derivatives as candidates for extracorporeal adsorption of Factor VIII antibodies in the management of haemophiliac patients.
    Boisson-Vidal C; Haouam M; Lakhiari H; Huguet H; Dahri L; Sultan Y; Jozefonvicz J; Siali R
    Vox Sang; 2002 Oct; 83(3):214-21. PubMed ID: 12366762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity are present in plasma of nonresponder patients with severe hemophilia A and in normal polyclonal human IgG.
    Moreau A; Lacroix-Desmazes S; Stieltjes N; Saenko E; Kaveri SV; D'Oiron R; Sultan Y; Scandella D; Kazatchkine MD
    Blood; 2000 Jun; 95(11):3435-41. PubMed ID: 10828026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B; Dasgupta S; Dimitrov JD; Bayry J; Lévesque H; Borg JY; Borel-Derlon A; Rao DN; Friboulet A; Kaveri SV; Lacroix-Desmazes S
    J Immunol; 2008 Jun; 180(11):7714-20. PubMed ID: 18490775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic antibodies to factor VIII in haemophilia A.
    Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S31-4. PubMed ID: 14567533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to factor VIII with catalytic activity.
    Bayry J; Lacroix-Desmazes S; Pashov A; Stahl D; Hoebeke J; Kazatchkine MD; Kaveri SV
    Autoimmun Rev; 2003 Jan; 2(1):30-5. PubMed ID: 12848973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG; Velloso-Rodrigues C; Moreau V; Nguyen C; Villard S; Belisário AR; Granier C; Santoro MM
    Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII.
    Sawamoto Y; Shima M; Tanaka I; Nakai H; Kamisue S; Scandella D; Yoshioka A
    Int J Hematol; 1997 Feb; 65(2):151-8. PubMed ID: 9071819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IX.
    Knöbl P; Derfler K
    Vox Sang; 1999; 77 Suppl 1():57-64. PubMed ID: 10529691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of inhibitors to factor VIII in patients with haemophilia A.
    Lacroix-Desmazes S; Misra N; Bayry J; Artaud C; Drayton B; Kaveri SV; Kazatchkine MD
    Haemophilia; 2002 May; 8(3):273-9. PubMed ID: 12010423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor.
    Villard S; Lacroix-Desmazes S; Kieber-Emmons T; Piquer D; Grailly S; Benhida A; Kaveri SV; Saint-Remy JM; Granier C
    Blood; 2003 Aug; 102(3):949-52. PubMed ID: 12676786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of factor VIII inhibitor antibodies of Chinese origin.
    Huang CC; Shen MC; Chen JY; Hung MH; Hsu TC; Lin SW
    Br J Haematol; 2001 Jun; 113(4):915-24. PubMed ID: 11442484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic activity of antibodies against factor VIII in patients with hemophilia A.
    Lacroix-Desmazes S; Moreau A; Sooryanarayana ; Bonnemain C; Stieltjes N; Pashov A; Sultan Y; Hoebeke J; Kazatchkine MD; Kaveri SV
    Nat Med; 1999 Sep; 5(9):1044-7. PubMed ID: 10470082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
    Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
    Lebreton A; Moreau V; Lapalud P; Cayzac C; André S; Nguyen C; Schved JF; Lavigne G; Granier C
    Br J Haematol; 2011 Nov; 155(4):487-97. PubMed ID: 21933172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.